Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells

PURPOSE: Although hepatectomy and liver transplantation surgery for hepatocellular carcinoma (HCC) are effective treatment modalities, the risk of recurrence remains high, particularly in patients with a high number of circulating tumor cells (CTCs) expressing cancer stem/progenitor cell markers. An...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Hsueh-Chou, Yeh, Chun-Chieh, Jeng, Long-Bin, Huang, Shang-Fen, Liao, Pei-Ying, Lei, Fu-Ju, Cheng, Wei-Chun, Hsu, Cheng-Lung, Cai, Xiujun, Chang, Chawnshang, Ma, Wen-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216809/
https://www.ncbi.nlm.nih.gov/pubmed/27340775
http://dx.doi.org/10.18632/oncotarget.10186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216809/
https://www.ncbi.nlm.nih.gov/pubmed/27340775
http://dx.doi.org/10.18632/oncotarget.10186

Ejemplares similares